Otolaryngology (ENT)
ENT Clinical Research
ENT disorders impact millions worldwide, affecting breathing, hearing, and quality of life. CenExel partners with sponsors to advance innovative ENT therapies through precise, patient-focused clinical research across diverse populations.



Studies Conducted
Trial Participants
Active Sites
Leading ENT Clinical Research
Complex ENT trials require specialized expertise and advanced diagnostic capabilities. CenExel’s experienced teams support studies across ear, nose, and throat conditions — ensuring high-quality data and efficient execution from first-patient-in to last-patient-out.
Our sites integrate clinical expertise with cutting-edge tools to evaluate outcomes in respiratory, auditory, and sinus-related disorders.
We support a wide range of ENT conditions including sinusitis, hearing disorders, sleep apnea, and rare otolaryngology indications across adult and pediatric populations.
ENT Conditions We Research
Our ENT research sites support a broad spectrum of conditions — from common sinus and allergy disorders to complex hearing and airway diseases.
Chronic Sinusitis
Allergic Rhinitis
Nasal Polyps
Obstructive Sleep Apnea (OSA)
Tonsillitis
Hearing Loss
Tinnitus
Otitis Media
Deviated Septum
Laryngitis
Why Sponsors Choose CenExel for ENT
Our ENT expertise extends beyond patient enrollment—we deliver specialized clinical insight, streamlined operations, and high-quality data to support successful outcomes and regulatory confidence across ear, nose, and throat studies.
01
Specialized ENT Expertise
Our investigators and site teams have deep experience in ENT trials, ensuring accurate diagnosis and high-quality data collection.
02
Advanced Diagnostics
We utilize modern tools including imaging, endoscopy, and audiology testing to support precise clinical evaluations.
03
Diverse Patient Access
Access to broad and diverse patient populations enables faster recruitment and real-world representation.
04
Efficient Enrollment
Our recruitment strategies consistently meet enrollment goals with speed and accuracy.
Supported Trial Phases
CenExel supports early and late-phase ENT clinical trials — from first-in-human studies through Phase IV post-market research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
ENT Task Force
CenExel’s ENT task force brings together specialists in otolaryngology, respiratory care, and audiology. Our multidisciplinary approach ensures precise study execution across sinus, airway, and hearing-related conditions, delivering reliable outcomes across diverse patient populations.
Active Sites
15 Sites
Also in Gastroenterology & Related Areas
Therapeutic Area
Respiratory Health
Upper airway and breathing-related conditions including allergies and sleep disorders.
Therapeutic Area
Allergy & Immunology
Immune-related conditions impacting nasal and sinus health.
Therapeutic Area
Neurology
Conditions affecting hearing, tinnitus, and vestibular disorders.
